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ABSTRACT 
This case concerned a female patient with a complaint 
of pain in the anterior region of her left knee during and 
after sports activities, followed by joint blockage three 
months ago. From imaging examinations, simple radio-
graphy of the knee was normal and magnetic resonan-
ce showed a solid expansive mass, possibly correspon-
ding to soft-tissue chondroma or focal nodular synovitis.
INTRODUCTION
Intra-articular giant cell tumor or localized pig-
mented villonodular synovitis (PVNS) is a rare le-
sion. Moreover, the nomenclature used by patholo-
gists or even by some other authors tends to lead to 
diagnostic doubts.
In 1852, Chassaignac(1) was the first to describe 
a nodular lesion that originated in the flexor tendon 
sheaths of the fingers. In 1864, Simon(2) described the 
localized form of the disease in the knee, and in 1909, 
Moser(3) described the diffuse form of the disease. In 
1941, Jaffe et al(4) proposed the term pigmented villo-
nodular synovitis for these manifestations.
The nomenclature used today is as described 
by Granowitz et al(5), in which the term pigmented 
villonodular synovitis is used for intra-articular 
findings; pigmented villonodular bursitis is used 
for localized lesions in bursas; and pigmented 
villonodular tenosynovitis is used for lesions 
originating from the tendon sheath, also known as 
giant cell tumors of the tendon sheath. Pigmented 
villonodular synovitis is divided into the diffuse form 
and the localized form.
The nomenclature used by pathologists or in 
scientific articles can often be confusing. The use of 
synonyms such as intra-articular giant cell tumor or 
giant cell-like tumor causes confusion among non-
-specialist physicians and patients.
Villonodular synovitis may be diffuse or locali-
zed, and the etiology remains uncertain. It is obser-
ved in most of the cases among patients between 20 
and 50 years of age, with slightly higher prevalence 
among females(4,6).
The treatment is based on resection of the lesion 
by means of arthroscopy and/or open surgery, with a 
local recurrence rate of 18 to 46%(7,8).
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Arthroscopic resection of the lesion was performed, and 
the diagnosis of diffuse giant cell tumor resembling loca-
lized pigmented villonodular synovitis (PVNS) was made 
from the result of the anatomopathological examination. 
The patient presented good clinical evolution, with disa-
ppearance of symptoms and return to physical activities. 
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CLINICAL CASE
The patient was a 37-year-old white female small 
trader who had presented pain in the anterior region of 
her left knee during and after sports activities, follo-
wed by joint blockage over the three-month period 
prior to examination. Orthopedic physical examina-
tion showed good alignment of the lower limbs, ab-
sence of edema or joint effusion and muscle atrophy 
in the vastus medialis obliquus. She presented pain on 
compression of the femoropatellar joint, with negati-
ve meniscal and ligament tests, and absence of signs 
of joint instability. Her range of motion was com-
plete and free from pain. There were no other signs 
or symptoms and her personal and family histories 
were unremarkable. Imaging examinations were per-
formed: simple radiography of the left knee in frontal, 
lateral and axial views, with normal results (Figure 1 
and Figure 2); and magnetic resonance imaging (Figu-
res 3 and Figure 4). The latter showed intra-substance 
degenerative abnormalities in the posterior cornua of 
the medial and lateral menisci, and solid expansive 
formation of pre-femoral fat, which could correspond 
to soft-tissue chondroma or focal nodular synovitis. 
The patient underwent arthroscopy (Figure 5 and 
Figure 6) in the left knee, with marginal resection of 
the lesion. The resected material was sent for ana-
tomopathological examination. The anatomopatho-
logical report (Figure 7 and Figure 8) showed that 
Figure 1- Radiograph on the left knee, in frontal view: normal 
results.
Figure 2 – Radiograph on the left knee, in lateral view: normal 
results.
Figure 3 – Sagittal T1-weighted magnetic resonance image 
showing nodulation in the retropatellar region. 
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this was a well-circumscribed neoplasm consisting 
of diffusely distributed epithelioid cells interspersed 
with dense connective tissue/giant cell-like tumor. 
Immunohistochemical analysis showed that the ne-
oplasm had the profile of giant cell-like tumor/pig-
mented villonodular synovitis. 
On the first postoperative day, the patient was 
already asymptomatic. Thirty days after surgery, she 
was released to perform all her activities. She will be 
followed up with magnetic resonance imaging every 
six months over the first year and then annually
for two years.
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DISCUSSION
Pigmented villonodular synovitis comprises a 
group of pathological conditions with similar anato-
mopathological characteristics. PVNS is a rare disease 
with 1.8 new cases per year, per million individuals(9). 
The nomenclature of the disease that is sometimes 
used in pathology reports or scientific studies is often 
confusing and leads to doubtful diagnoses.
We observed that some published studies have des-
cribed the lesion as synovial giant cell tumor, while 
others have described it as localized pigmented villo-
nodular synovitis, not knowing whether the lesion 
is intra-synovial or from the tendon sheath(10). The 
nomenclature proposed by Granowitz et al(5) deter-
mines that the term pigmented villonodular synovitis 
should be used for intra-articular findings; pigmen-
ted villonodular bursitis for lesions that are localized 
in bursas; and pigmented villonodular tenosynovitis 
for lesions originating from the tendon sheath, also
known as giant cell tumors of the tendon sheath.  
Pigmented villonodular synovitis is a rare disease, 
but it involves the knee in 80% of the cases. The intra-
-articular disease may be localized or diffuse. PVNS 
is characterized by hyperplasia of the synovium or 
tendon sheath, with notable proliferation of stromal 
cells, large quantities of intra and extracellular hemo-
siderin and multinucleated giant cells. The disease is 
most prevalent in patients between the ages of 20 and 
50 years, with slight predominance among females(11).
The etiology has not been established, but it may 
be associated with repeated hemarthrosis. Other pos-
sibilities suggested in the literature include: benign 
Figure 4 – Axial T2-weighted magnetic resonance image with 
contrast, showing nodulation in the retropatellar region.
Figures 5 and 6 – Arthroscopic resection of the lesion.
Figure 7 – Slide stained with hematoxylin-eosin, showing 
proliferation of diffusely distributed epithelioid cells interspersed 
with dense connective tissue. Macrophages with hemosiderin 
accumulations in the cytoplasm and multinucleated giant cells 
can be seen. 
Figure 8 – Detail of a multinucleated giant cell.
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neoplastic processes, reactions to unknown stimuli 
and reactions to repeated episodes of trauma(7,12).
The symptoms are progressive. Pain, repeated non-
-traumatic joint effusion and limitation of joint range of 
motion are observed in the diffuse form. The localized 
form is difficult to diagnose, since the symptoms may 
mimic meniscal lesions or intra-articular free bodies, 
and complaints of abnormal mobility(7,13). In the physi-
cal examination, the findings are nonspecific: patients 
may be oligosymptomatic, like in the case presented 
here, or they may present local heat, joint effusion, 
diminished range of motion, pain, muscle atrophy and 
a palpable mass. Meniscal or ligament abnormalities 
are generally not found. Because of the difficulties in 
making a conclusive clinical diagnosis, complementary 
imaging examinations are necessary(7,12,13).
The important complementary examinations are 
simple radiography and magnetic resonance imaging. 
In cases at the initial stage, simple radiography ge-
nerally shows normal results, although there may be 
erosion with a periosteal reaction in regions without 
loading. In chronic cases, mirror-image erosive le-
sions are found in the affected joint(14).
Magnetic resonance imaging is an important exa-
mination for establishing the diagnostic hypothesis 
and directing the treatment. Areas of low signal are 
observed with T1 and T2 weighting in the synovial 
membrane(14). In PVNS, the synovial membrane is 
irregular, and joint effusion is frequently seen.
The histological findings show that these lesions 
are well differentiated, with destructive proliferation 
of synovial-like mononuclear cells, in association with 
multinucleated giant cells, xanthomized macrophages, 
hemosiderophages and inflammatory cells(8,15).
PVNS is a benign lesion. A potential for malignant 
degeneration has been reported, but is extremely rare(8).
The recommended treatment for PVNS is resection 
of the lesion. Synovectomy by means of multiple-por-
tal arthroscopy is the treatment of choice. A posterior 
open access may be necessary in patients with exten-
sion of the disease to the posterior and extracapsular 
regions(7,12,16). Arthroscopic resection is the method 
most indicated for treating PVNS. Arthroscopy causes 
less injury to the structures of the knee and leads to 
earlier recovery(7, 12).  Radiotherapy is used in cases 
of multiple recurrence(17,18,19).
Patients are followed up by means of periodic mag-
netic resonance imaging, every six to twelve months. 
The prognosis is good, but local recurrence occurs in 
12 to 48% of the cases(5,10).
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